nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—skin cancer	0.715	1	CbGaD
Risedronate—FDPS—Sorafenib—Vismodegib—skin cancer	0.00729	1	CbGdCrCtD
Risedronate—FDPS—hair follicle—skin cancer	0.00647	0.115	CbGeAlD
Risedronate—PTGS2—leg—skin cancer	0.00545	0.0973	CbGeAlD
Risedronate—PTGS2—hindlimb—skin cancer	0.00487	0.0869	CbGeAlD
Risedronate—FDPS—nipple—skin cancer	0.00438	0.0783	CbGeAlD
Risedronate—PTGS2—appendage—skin cancer	0.00418	0.0745	CbGeAlD
Risedronate—PTGS2—skin epidermis—skin cancer	0.00347	0.062	CbGeAlD
Risedronate—FDPS—connective tissue—skin cancer	0.00311	0.0555	CbGeAlD
Risedronate—FDPS—skin of body—skin cancer	0.00281	0.0501	CbGeAlD
Risedronate—FDPS—mammalian vulva—skin cancer	0.00256	0.0457	CbGeAlD
Risedronate—PTGS2—endothelium—skin cancer	0.00252	0.045	CbGeAlD
Risedronate—PTGS2—blood vessel—skin cancer	0.00232	0.0415	CbGeAlD
Risedronate—FDPS—lymphoid tissue—skin cancer	0.00227	0.0406	CbGeAlD
Risedronate—FDPS—female reproductive system—skin cancer	0.00219	0.0391	CbGeAlD
Risedronate—FDPS—head—skin cancer	0.00183	0.0327	CbGeAlD
Risedronate—FDPS—lymph node—skin cancer	0.00128	0.0229	CbGeAlD
Risedronate—PTGS2—connective tissue—skin cancer	0.00119	0.0213	CbGeAlD
Risedronate—PTGS2—epithelium—skin cancer	0.00113	0.0202	CbGeAlD
Risedronate—PTGS2—skin of body—skin cancer	0.00108	0.0192	CbGeAlD
Risedronate—PTGS2—lymphoid tissue—skin cancer	0.000872	0.0156	CbGeAlD
Risedronate—PTGS2—female reproductive system—skin cancer	0.000841	0.015	CbGeAlD
Risedronate—PTGS2—head—skin cancer	0.000702	0.0125	CbGeAlD
Risedronate—Hypertension—Imiquimod—skin cancer	0.000496	0.00224	CcSEcCtD
Risedronate—PTGS2—lymph node—skin cancer	0.000492	0.00878	CbGeAlD
Risedronate—Pneumonia—Dactinomycin—skin cancer	0.00049	0.00221	CcSEcCtD
Risedronate—Chest pain—Imiquimod—skin cancer	0.000489	0.00221	CcSEcCtD
Risedronate—Arthralgia—Imiquimod—skin cancer	0.000489	0.00221	CcSEcCtD
Risedronate—Myalgia—Imiquimod—skin cancer	0.000489	0.00221	CcSEcCtD
Risedronate—Anxiety—Imiquimod—skin cancer	0.000488	0.0022	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000486	0.00219	CcSEcCtD
Risedronate—Oesophagitis—Docetaxel—skin cancer	0.000479	0.00216	CcSEcCtD
Risedronate—Dry mouth—Imiquimod—skin cancer	0.000479	0.00216	CcSEcCtD
Risedronate—Bronchitis—Temozolomide—skin cancer	0.000476	0.00214	CcSEcCtD
Risedronate—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000475	0.00214	CcSEcCtD
Risedronate—Fatigue—Vemurafenib—skin cancer	0.000474	0.00214	CcSEcCtD
Risedronate—Neoplasm—Docetaxel—skin cancer	0.000474	0.00214	CcSEcCtD
Risedronate—Haemoglobin—Bleomycin—skin cancer	0.000472	0.00213	CcSEcCtD
Risedronate—Nasopharyngitis—Fluorouracil—skin cancer	0.000471	0.00213	CcSEcCtD
Risedronate—Constipation—Vemurafenib—skin cancer	0.000471	0.00212	CcSEcCtD
Risedronate—Haemorrhage—Bleomycin—skin cancer	0.000469	0.00212	CcSEcCtD
Risedronate—Infection—Imiquimod—skin cancer	0.000466	0.0021	CcSEcCtD
Risedronate—Muscular weakness—Fluorouracil—skin cancer	0.000465	0.0021	CcSEcCtD
Risedronate—Shock—Imiquimod—skin cancer	0.000462	0.00208	CcSEcCtD
Risedronate—Nervous system disorder—Imiquimod—skin cancer	0.00046	0.00208	CcSEcCtD
Risedronate—Upper respiratory tract infection—Temozolomide—skin cancer	0.00046	0.00207	CcSEcCtD
Risedronate—Skin disorder—Imiquimod—skin cancer	0.000456	0.00206	CcSEcCtD
Risedronate—Angina pectoris—Fluorouracil—skin cancer	0.000444	0.002	CcSEcCtD
Risedronate—Pneumonia—Temozolomide—skin cancer	0.000443	0.002	CcSEcCtD
Risedronate—Infestation—Temozolomide—skin cancer	0.000441	0.00199	CcSEcCtD
Risedronate—Infestation NOS—Temozolomide—skin cancer	0.000441	0.00199	CcSEcCtD
Risedronate—Depression—Temozolomide—skin cancer	0.00044	0.00198	CcSEcCtD
Risedronate—Body temperature increased—Vemurafenib—skin cancer	0.000435	0.00196	CcSEcCtD
Risedronate—Pharyngitis—Dactinomycin—skin cancer	0.000434	0.00196	CcSEcCtD
Risedronate—Urinary tract infection—Temozolomide—skin cancer	0.000429	0.00193	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000428	0.00193	CcSEcCtD
Risedronate—Insomnia—Imiquimod—skin cancer	0.000424	0.00191	CcSEcCtD
Risedronate—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000423	0.00191	CcSEcCtD
Risedronate—Paraesthesia—Imiquimod—skin cancer	0.000421	0.0019	CcSEcCtD
Risedronate—Dyspnoea—Imiquimod—skin cancer	0.000418	0.00189	CcSEcCtD
Risedronate—Hepatobiliary disease—Temozolomide—skin cancer	0.000417	0.00188	CcSEcCtD
Risedronate—Sinusitis—Temozolomide—skin cancer	0.000414	0.00187	CcSEcCtD
Risedronate—Dyspepsia—Imiquimod—skin cancer	0.000413	0.00186	CcSEcCtD
Risedronate—Pneumonia—Fluorouracil—skin cancer	0.000409	0.00184	CcSEcCtD
Risedronate—Infestation—Fluorouracil—skin cancer	0.000406	0.00183	CcSEcCtD
Risedronate—Infestation NOS—Fluorouracil—skin cancer	0.000406	0.00183	CcSEcCtD
Risedronate—Hypersensitivity—Vemurafenib—skin cancer	0.000405	0.00183	CcSEcCtD
Risedronate—Gastrointestinal disorder—Imiquimod—skin cancer	0.000405	0.00183	CcSEcCtD
Risedronate—Fatigue—Imiquimod—skin cancer	0.000405	0.00182	CcSEcCtD
Risedronate—Pain—Imiquimod—skin cancer	0.000401	0.00181	CcSEcCtD
Risedronate—Haemoglobin—Temozolomide—skin cancer	0.000398	0.00179	CcSEcCtD
Risedronate—Haemorrhage—Temozolomide—skin cancer	0.000396	0.00178	CcSEcCtD
Risedronate—Urinary tract infection—Fluorouracil—skin cancer	0.000395	0.00178	CcSEcCtD
Risedronate—Conjunctivitis—Fluorouracil—skin cancer	0.000395	0.00178	CcSEcCtD
Risedronate—Asthenia—Vemurafenib—skin cancer	0.000395	0.00178	CcSEcCtD
Risedronate—Pharyngitis—Temozolomide—skin cancer	0.000393	0.00177	CcSEcCtD
Risedronate—Urinary tract disorder—Temozolomide—skin cancer	0.000391	0.00176	CcSEcCtD
Risedronate—Oedema peripheral—Temozolomide—skin cancer	0.00039	0.00176	CcSEcCtD
Risedronate—Pruritus—Vemurafenib—skin cancer	0.000389	0.00176	CcSEcCtD
Risedronate—Connective tissue disorder—Temozolomide—skin cancer	0.000389	0.00175	CcSEcCtD
Risedronate—Urethral disorder—Temozolomide—skin cancer	0.000388	0.00175	CcSEcCtD
Risedronate—Gastrointestinal pain—Imiquimod—skin cancer	0.000384	0.00173	CcSEcCtD
Risedronate—Sinusitis—Fluorouracil—skin cancer	0.000381	0.00172	CcSEcCtD
Risedronate—Pain in extremity—Docetaxel—skin cancer	0.00038	0.00172	CcSEcCtD
Risedronate—Anaemia—Bleomycin—skin cancer	0.000378	0.0017	CcSEcCtD
Risedronate—Diarrhoea—Vemurafenib—skin cancer	0.000376	0.0017	CcSEcCtD
Risedronate—Urticaria—Imiquimod—skin cancer	0.000373	0.00168	CcSEcCtD
Risedronate—Body temperature increased—Imiquimod—skin cancer	0.000371	0.00167	CcSEcCtD
Risedronate—Abdominal pain—Imiquimod—skin cancer	0.000371	0.00167	CcSEcCtD
Risedronate—Eye disorder—Temozolomide—skin cancer	0.00037	0.00167	CcSEcCtD
Risedronate—Tinnitus—Temozolomide—skin cancer	0.000369	0.00166	CcSEcCtD
Risedronate—Cardiac disorder—Temozolomide—skin cancer	0.000367	0.00166	CcSEcCtD
Risedronate—Haemoglobin—Fluorouracil—skin cancer	0.000367	0.00165	CcSEcCtD
Risedronate—Rhinitis—Fluorouracil—skin cancer	0.000366	0.00165	CcSEcCtD
Risedronate—Haemorrhage—Fluorouracil—skin cancer	0.000365	0.00164	CcSEcCtD
Risedronate—Dizziness—Vemurafenib—skin cancer	0.000364	0.00164	CcSEcCtD
Risedronate—Pharyngitis—Fluorouracil—skin cancer	0.000362	0.00163	CcSEcCtD
Risedronate—Angiopathy—Temozolomide—skin cancer	0.000359	0.00162	CcSEcCtD
Risedronate—Immune system disorder—Temozolomide—skin cancer	0.000358	0.00161	CcSEcCtD
Risedronate—Mediastinal disorder—Temozolomide—skin cancer	0.000357	0.00161	CcSEcCtD
Risedronate—Cough—Bleomycin—skin cancer	0.000356	0.00161	CcSEcCtD
Risedronate—Anaemia—Dactinomycin—skin cancer	0.000352	0.00159	CcSEcCtD
Risedronate—Liver function test abnormal—Docetaxel—skin cancer	0.000351	0.00158	CcSEcCtD
Risedronate—Vomiting—Vemurafenib—skin cancer	0.00035	0.00158	CcSEcCtD
Risedronate—Myalgia—Bleomycin—skin cancer	0.000348	0.00157	CcSEcCtD
Risedronate—Chest pain—Bleomycin—skin cancer	0.000348	0.00157	CcSEcCtD
Risedronate—Abdominal pain upper—Docetaxel—skin cancer	0.000347	0.00157	CcSEcCtD
Risedronate—Rash—Vemurafenib—skin cancer	0.000347	0.00156	CcSEcCtD
Risedronate—Mental disorder—Temozolomide—skin cancer	0.000347	0.00156	CcSEcCtD
Risedronate—Dermatitis—Vemurafenib—skin cancer	0.000347	0.00156	CcSEcCtD
Risedronate—Hypersensitivity—Imiquimod—skin cancer	0.000346	0.00156	CcSEcCtD
Risedronate—Headache—Vemurafenib—skin cancer	0.000345	0.00155	CcSEcCtD
Risedronate—Malnutrition—Temozolomide—skin cancer	0.000345	0.00155	CcSEcCtD
Risedronate—Breast disorder—Docetaxel—skin cancer	0.000344	0.00155	CcSEcCtD
Risedronate—Nasopharyngitis—Docetaxel—skin cancer	0.00034	0.00153	CcSEcCtD
Risedronate—Asthenia—Imiquimod—skin cancer	0.000337	0.00152	CcSEcCtD
Risedronate—Back pain—Temozolomide—skin cancer	0.000333	0.0015	CcSEcCtD
Risedronate—Pruritus—Imiquimod—skin cancer	0.000332	0.0015	CcSEcCtD
Risedronate—Infection—Bleomycin—skin cancer	0.000331	0.00149	CcSEcCtD
Risedronate—Nausea—Vemurafenib—skin cancer	0.000327	0.00147	CcSEcCtD
Risedronate—Arrhythmia—Fluorouracil—skin cancer	0.000326	0.00147	CcSEcCtD
Risedronate—Myalgia—Dactinomycin—skin cancer	0.000324	0.00146	CcSEcCtD
Risedronate—Diarrhoea—Imiquimod—skin cancer	0.000321	0.00145	CcSEcCtD
Risedronate—Angina pectoris—Docetaxel—skin cancer	0.00032	0.00144	CcSEcCtD
Risedronate—Anaemia—Temozolomide—skin cancer	0.000318	0.00144	CcSEcCtD
Risedronate—Angioedema—Temozolomide—skin cancer	0.000315	0.00142	CcSEcCtD
Risedronate—Dizziness—Imiquimod—skin cancer	0.00031	0.0014	CcSEcCtD
Risedronate—Vertigo—Temozolomide—skin cancer	0.00031	0.0014	CcSEcCtD
Risedronate—Infection—Dactinomycin—skin cancer	0.000309	0.00139	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000304	0.00137	CcSEcCtD
Risedronate—Cough—Temozolomide—skin cancer	0.000301	0.00136	CcSEcCtD
Risedronate—Paraesthesia—Bleomycin—skin cancer	0.000299	0.00135	CcSEcCtD
Risedronate—Vomiting—Imiquimod—skin cancer	0.000298	0.00135	CcSEcCtD
Risedronate—Hypertension—Temozolomide—skin cancer	0.000297	0.00134	CcSEcCtD
Risedronate—Dyspnoea—Bleomycin—skin cancer	0.000297	0.00134	CcSEcCtD
Risedronate—Rash—Imiquimod—skin cancer	0.000296	0.00133	CcSEcCtD
Risedronate—Dermatitis—Imiquimod—skin cancer	0.000296	0.00133	CcSEcCtD
Risedronate—Pneumonia—Docetaxel—skin cancer	0.000295	0.00133	CcSEcCtD
Risedronate—Headache—Imiquimod—skin cancer	0.000294	0.00133	CcSEcCtD
Risedronate—Anaemia—Fluorouracil—skin cancer	0.000293	0.00132	CcSEcCtD
Risedronate—Myalgia—Temozolomide—skin cancer	0.000293	0.00132	CcSEcCtD
Risedronate—Arthralgia—Temozolomide—skin cancer	0.000293	0.00132	CcSEcCtD
Risedronate—Infestation—Docetaxel—skin cancer	0.000293	0.00132	CcSEcCtD
Risedronate—Infestation NOS—Docetaxel—skin cancer	0.000293	0.00132	CcSEcCtD
Risedronate—Anxiety—Temozolomide—skin cancer	0.000292	0.00132	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000291	0.00131	CcSEcCtD
Risedronate—Dry mouth—Temozolomide—skin cancer	0.000287	0.00129	CcSEcCtD
Risedronate—Pain—Bleomycin—skin cancer	0.000285	0.00129	CcSEcCtD
Risedronate—Conjunctivitis—Docetaxel—skin cancer	0.000285	0.00129	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000283	0.00128	CcSEcCtD
Risedronate—Infection—Temozolomide—skin cancer	0.000279	0.00126	CcSEcCtD
Risedronate—Nausea—Imiquimod—skin cancer	0.000279	0.00126	CcSEcCtD
Risedronate—Hepatobiliary disease—Docetaxel—skin cancer	0.000277	0.00125	CcSEcCtD
Risedronate—Nervous system disorder—Temozolomide—skin cancer	0.000276	0.00124	CcSEcCtD
Risedronate—Skin disorder—Temozolomide—skin cancer	0.000273	0.00123	CcSEcCtD
Risedronate—Myalgia—Fluorouracil—skin cancer	0.00027	0.00122	CcSEcCtD
Risedronate—Chest pain—Fluorouracil—skin cancer	0.00027	0.00122	CcSEcCtD
Risedronate—Fatigue—Dactinomycin—skin cancer	0.000268	0.00121	CcSEcCtD
Risedronate—Pain—Dactinomycin—skin cancer	0.000266	0.0012	CcSEcCtD
Risedronate—Urticaria—Bleomycin—skin cancer	0.000265	0.00119	CcSEcCtD
Risedronate—Haemoglobin—Docetaxel—skin cancer	0.000265	0.00119	CcSEcCtD
Risedronate—Rhinitis—Docetaxel—skin cancer	0.000264	0.00119	CcSEcCtD
Risedronate—Body temperature increased—Bleomycin—skin cancer	0.000264	0.00119	CcSEcCtD
Risedronate—Haemorrhage—Docetaxel—skin cancer	0.000263	0.00119	CcSEcCtD
Risedronate—Pharyngitis—Docetaxel—skin cancer	0.000261	0.00118	CcSEcCtD
Risedronate—Urinary tract disorder—Docetaxel—skin cancer	0.00026	0.00117	CcSEcCtD
Risedronate—Oedema peripheral—Docetaxel—skin cancer	0.000259	0.00117	CcSEcCtD
Risedronate—Connective tissue disorder—Docetaxel—skin cancer	0.000259	0.00117	CcSEcCtD
Risedronate—Urethral disorder—Docetaxel—skin cancer	0.000258	0.00116	CcSEcCtD
Risedronate—Infection—Fluorouracil—skin cancer	0.000257	0.00116	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000256	0.00116	CcSEcCtD
Risedronate—Insomnia—Temozolomide—skin cancer	0.000254	0.00115	CcSEcCtD
Risedronate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000254	0.00115	CcSEcCtD
Risedronate—Nervous system disorder—Fluorouracil—skin cancer	0.000254	0.00115	CcSEcCtD
Risedronate—Paraesthesia—Temozolomide—skin cancer	0.000252	0.00114	CcSEcCtD
Risedronate—Dyspnoea—Temozolomide—skin cancer	0.000251	0.00113	CcSEcCtD
Risedronate—Dyspepsia—Temozolomide—skin cancer	0.000248	0.00112	CcSEcCtD
Risedronate—Eye disorder—Docetaxel—skin cancer	0.000246	0.00111	CcSEcCtD
Risedronate—Body temperature increased—Dactinomycin—skin cancer	0.000246	0.00111	CcSEcCtD
Risedronate—Abdominal pain—Dactinomycin—skin cancer	0.000246	0.00111	CcSEcCtD
Risedronate—Hypersensitivity—Bleomycin—skin cancer	0.000246	0.00111	CcSEcCtD
Risedronate—Cardiac disorder—Docetaxel—skin cancer	0.000244	0.0011	CcSEcCtD
Risedronate—Gastrointestinal disorder—Temozolomide—skin cancer	0.000243	0.00109	CcSEcCtD
Risedronate—Fatigue—Temozolomide—skin cancer	0.000242	0.00109	CcSEcCtD
Risedronate—Constipation—Temozolomide—skin cancer	0.00024	0.00108	CcSEcCtD
Risedronate—Pain—Temozolomide—skin cancer	0.00024	0.00108	CcSEcCtD
Risedronate—Asthenia—Bleomycin—skin cancer	0.000239	0.00108	CcSEcCtD
Risedronate—Angiopathy—Docetaxel—skin cancer	0.000239	0.00108	CcSEcCtD
Risedronate—Immune system disorder—Docetaxel—skin cancer	0.000238	0.00107	CcSEcCtD
Risedronate—Mediastinal disorder—Docetaxel—skin cancer	0.000237	0.00107	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000236	0.00106	CcSEcCtD
Risedronate—Pruritus—Bleomycin—skin cancer	0.000236	0.00106	CcSEcCtD
Risedronate—Arrhythmia—Docetaxel—skin cancer	0.000235	0.00106	CcSEcCtD
Risedronate—Insomnia—Fluorouracil—skin cancer	0.000234	0.00106	CcSEcCtD
Risedronate—Paraesthesia—Fluorouracil—skin cancer	0.000233	0.00105	CcSEcCtD
Risedronate—Dyspnoea—Fluorouracil—skin cancer	0.000231	0.00104	CcSEcCtD
Risedronate—Mental disorder—Docetaxel—skin cancer	0.000231	0.00104	CcSEcCtD
Risedronate—Gastrointestinal pain—Temozolomide—skin cancer	0.00023	0.00104	CcSEcCtD
Risedronate—Malnutrition—Docetaxel—skin cancer	0.000229	0.00103	CcSEcCtD
Risedronate—Hypersensitivity—Dactinomycin—skin cancer	0.000229	0.00103	CcSEcCtD
Risedronate—Dyspepsia—Fluorouracil—skin cancer	0.000228	0.00103	CcSEcCtD
Risedronate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000224	0.00101	CcSEcCtD
Risedronate—Urticaria—Temozolomide—skin cancer	0.000223	0.00101	CcSEcCtD
Risedronate—Asthenia—Dactinomycin—skin cancer	0.000223	0.00101	CcSEcCtD
Risedronate—Body temperature increased—Temozolomide—skin cancer	0.000222	0.001	CcSEcCtD
Risedronate—Abdominal pain—Temozolomide—skin cancer	0.000222	0.001	CcSEcCtD
Risedronate—Back pain—Docetaxel—skin cancer	0.000222	0.000999	CcSEcCtD
Risedronate—Pain—Fluorouracil—skin cancer	0.000222	0.000999	CcSEcCtD
Risedronate—Muscle spasms—Docetaxel—skin cancer	0.00022	0.000993	CcSEcCtD
Risedronate—Diarrhoea—Dactinomycin—skin cancer	0.000213	0.000959	CcSEcCtD
Risedronate—Vomiting—Bleomycin—skin cancer	0.000212	0.000956	CcSEcCtD
Risedronate—Anaemia—Docetaxel—skin cancer	0.000212	0.000955	CcSEcCtD
Risedronate—Rash—Bleomycin—skin cancer	0.00021	0.000948	CcSEcCtD
Risedronate—Dermatitis—Bleomycin—skin cancer	0.00021	0.000947	CcSEcCtD
Risedronate—Hypersensitivity—Temozolomide—skin cancer	0.000207	0.000934	CcSEcCtD
Risedronate—Urticaria—Fluorouracil—skin cancer	0.000206	0.000928	CcSEcCtD
Risedronate—Syncope—Docetaxel—skin cancer	0.000205	0.000927	CcSEcCtD
Risedronate—Body temperature increased—Fluorouracil—skin cancer	0.000205	0.000924	CcSEcCtD
Risedronate—Asthenia—Temozolomide—skin cancer	0.000202	0.00091	CcSEcCtD
Risedronate—Loss of consciousness—Docetaxel—skin cancer	0.000201	0.000908	CcSEcCtD
Risedronate—Cough—Docetaxel—skin cancer	0.0002	0.000902	CcSEcCtD
Risedronate—Pruritus—Temozolomide—skin cancer	0.000199	0.000897	CcSEcCtD
Risedronate—Nausea—Bleomycin—skin cancer	0.000198	0.000893	CcSEcCtD
Risedronate—Hypertension—Docetaxel—skin cancer	0.000198	0.000892	CcSEcCtD
Risedronate—Vomiting—Dactinomycin—skin cancer	0.000198	0.000891	CcSEcCtD
Risedronate—Rash—Dactinomycin—skin cancer	0.000196	0.000884	CcSEcCtD
Risedronate—Arthralgia—Docetaxel—skin cancer	0.000195	0.00088	CcSEcCtD
Risedronate—Chest pain—Docetaxel—skin cancer	0.000195	0.00088	CcSEcCtD
Risedronate—Myalgia—Docetaxel—skin cancer	0.000195	0.00088	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000194	0.000874	CcSEcCtD
Risedronate—Diarrhoea—Temozolomide—skin cancer	0.000192	0.000868	CcSEcCtD
Risedronate—Hypersensitivity—Fluorouracil—skin cancer	0.000191	0.000861	CcSEcCtD
Risedronate—Dry mouth—Docetaxel—skin cancer	0.000191	0.00086	CcSEcCtD
Risedronate—Dizziness—Temozolomide—skin cancer	0.000186	0.000839	CcSEcCtD
Risedronate—Infection—Docetaxel—skin cancer	0.000186	0.000838	CcSEcCtD
Risedronate—Nausea—Dactinomycin—skin cancer	0.000185	0.000833	CcSEcCtD
Risedronate—Shock—Docetaxel—skin cancer	0.000184	0.00083	CcSEcCtD
Risedronate—Nervous system disorder—Docetaxel—skin cancer	0.000183	0.000827	CcSEcCtD
Risedronate—Pruritus—Fluorouracil—skin cancer	0.000183	0.000827	CcSEcCtD
Risedronate—Skin disorder—Docetaxel—skin cancer	0.000182	0.000819	CcSEcCtD
Risedronate—Vomiting—Temozolomide—skin cancer	0.000179	0.000806	CcSEcCtD
Risedronate—Rash—Temozolomide—skin cancer	0.000177	0.0008	CcSEcCtD
Risedronate—Diarrhoea—Fluorouracil—skin cancer	0.000177	0.000799	CcSEcCtD
Risedronate—Dermatitis—Temozolomide—skin cancer	0.000177	0.000799	CcSEcCtD
Risedronate—Headache—Temozolomide—skin cancer	0.000176	0.000794	CcSEcCtD
Risedronate—Dizziness—Fluorouracil—skin cancer	0.000171	0.000773	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00017	0.000768	CcSEcCtD
Risedronate—Insomnia—Docetaxel—skin cancer	0.000169	0.000763	CcSEcCtD
Risedronate—Paraesthesia—Docetaxel—skin cancer	0.000168	0.000757	CcSEcCtD
Risedronate—Nausea—Temozolomide—skin cancer	0.000167	0.000753	CcSEcCtD
Risedronate—Dyspnoea—Docetaxel—skin cancer	0.000167	0.000752	CcSEcCtD
Risedronate—Vomiting—Fluorouracil—skin cancer	0.000165	0.000743	CcSEcCtD
Risedronate—Dyspepsia—Docetaxel—skin cancer	0.000165	0.000742	CcSEcCtD
Risedronate—Rash—Fluorouracil—skin cancer	0.000163	0.000737	CcSEcCtD
Risedronate—Dermatitis—Fluorouracil—skin cancer	0.000163	0.000736	CcSEcCtD
Risedronate—Headache—Fluorouracil—skin cancer	0.000162	0.000732	CcSEcCtD
Risedronate—Gastrointestinal disorder—Docetaxel—skin cancer	0.000161	0.000728	CcSEcCtD
Risedronate—Fatigue—Docetaxel—skin cancer	0.000161	0.000727	CcSEcCtD
Risedronate—Pain—Docetaxel—skin cancer	0.00016	0.000721	CcSEcCtD
Risedronate—Constipation—Docetaxel—skin cancer	0.00016	0.000721	CcSEcCtD
Risedronate—Nausea—Fluorouracil—skin cancer	0.000154	0.000694	CcSEcCtD
Risedronate—Gastrointestinal pain—Docetaxel—skin cancer	0.000153	0.00069	CcSEcCtD
Risedronate—Abdominal pain—Docetaxel—skin cancer	0.000148	0.000667	CcSEcCtD
Risedronate—Body temperature increased—Docetaxel—skin cancer	0.000148	0.000667	CcSEcCtD
Risedronate—Hypersensitivity—Docetaxel—skin cancer	0.000138	0.000621	CcSEcCtD
Risedronate—Asthenia—Docetaxel—skin cancer	0.000134	0.000605	CcSEcCtD
Risedronate—Pruritus—Docetaxel—skin cancer	0.000132	0.000597	CcSEcCtD
Risedronate—Diarrhoea—Docetaxel—skin cancer	0.000128	0.000577	CcSEcCtD
Risedronate—Dizziness—Docetaxel—skin cancer	0.000124	0.000558	CcSEcCtD
Risedronate—Vomiting—Docetaxel—skin cancer	0.000119	0.000536	CcSEcCtD
Risedronate—Rash—Docetaxel—skin cancer	0.000118	0.000532	CcSEcCtD
Risedronate—Dermatitis—Docetaxel—skin cancer	0.000118	0.000531	CcSEcCtD
Risedronate—Headache—Docetaxel—skin cancer	0.000117	0.000528	CcSEcCtD
Risedronate—Nausea—Docetaxel—skin cancer	0.000111	0.000501	CcSEcCtD
